GC39825
XMU-MP-3
Also known as N-[3-[2-[(2,5-dimethylpyrazol-3-yl)amino]-8-methyl-5,7-dihydropyrimido[4,5-d]pyrimidin-6-yl]-4-methylphenyl]-3-(trifluoromethyl)benzamide
XMU-MP-3 is a potent non-covalent BTK inhibitor with IC50s of 10·7 nM and 17·0 nM for BTK WT and BTK C481S mutation in the presence of 10 μM ATP, respectively· XMU-MP-3 also induces apoptosis
ChemicalCAS2031152-08-4MW536.55FormulaC27H27F3N8O
- CAS number
- 2031152-08-4
- Molecular weight
- 536.55
- Formula
- C27H27F3N8O
- Solubility
- Soluble in DMSO
- InChIKey
- MCEWMWAJAOMTBE-UHFFFAOYSA-N
- Catalogue number
- GC39825
- Brand
- GLPBIO
Computed properties PubChem CID 122648639 · XLogP 5.2 · TPSA 91.2 Ų · H-bond donors 2
- XLogP
- 5.2
- TPSA
- 91.2 Ų
- H-bond donors
- 2
- H-bond acceptors
- 10
- Rotatable bonds
- 5
- Heavy atoms
- 39
SMILES CC1=C(C=C(C=C1)NC(=O)C2=CC(=CC=C2)C(F)(F)F)N3CC4=CN=C(N=C4N(C3)C)NC5=CC(=NN5C)C
Computed descriptors from PubChem (CID 122648639), public domain. Identity cross-checked against the supplier's molecular formula and weight — verify before use.
Ordering in Israel
- Lead time
- Ships from the manufacturer to your lab in 8–14 business days; customs and cold chain handled by LABO Scientific.
- Pricing
- Quoted in ILS, excl. VAT. Add the item to your quote and we confirm the final price, usually the same business day.
- Documents
- Lot certificate of analysis and manufacturer SDS are emailed with your order confirmation.
- Who we serve
- Universities, hospitals and biotech companies across Israel. Research use only — not for diagnostic or therapeutic use.
- Questions
- WhatsApp · +972-55-990-7576 · orders@labo.co.il